112 related articles for article (PubMed ID: 8610616)
1. Treatment of viral myocarditis with focus on captopril.
Rezkalla SH; Raikar S; Kloner RA
Am J Cardiol; 1996 Mar; 77(8):634-7. PubMed ID: 8610616
[No Abstract] [Full Text] [Related]
2. Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage.
Abdel-Wahab BA; Metwally ME; El-khawanki MM; Hashim AM
Chem Biol Interact; 2014 Jun; 216():43-52. PubMed ID: 24709159
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis.
Godsel LM; Leon JS; Engman DM
Curr Pharm Des; 2003; 9(9):723-35. PubMed ID: 12570790
[TBL] [Abstract][Full Text] [Related]
4. Captopril ameliorates myocarditis in acute experimental Chagas disease.
Leon JS; Wang K; Engman DM
Circulation; 2003 May; 107(17):2264-9. PubMed ID: 12707246
[TBL] [Abstract][Full Text] [Related]
5. [Effects of captopril on myocardial energy metabolism in mice with viral myocarditis].
Chen JB; Rao BF; Chang J; Liao XG; Cao YD
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):485-8. PubMed ID: 12919652
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS-1 contributes to the antifibrotic effect of captopril by accelerating the degradation of type I collagen in chronic viral myocarditis.
Guo C; Wang Y; Liang H; Zhang J
Eur J Pharmacol; 2010 Mar; 629(1-3):104-10. PubMed ID: 20006601
[TBL] [Abstract][Full Text] [Related]
7. Captopril in acute pulmonary edema: measuring the benefit.
Christenson JM
Acad Emerg Med; 1996 Mar; 3(3):192-3. PubMed ID: 8673770
[No Abstract] [Full Text] [Related]
8. Parvovirus b19-induced myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging.
Basic D; Gupta S; Kwong RY
Circulation; 2010 Feb; 121(7):e40-2. PubMed ID: 20177002
[No Abstract] [Full Text] [Related]
9. Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.
Bahk TJ; Daniels MD; Leon JS; Wang K; Engman DM
Int J Cardiol; 2008 Mar; 125(1):85-93. PubMed ID: 17588693
[TBL] [Abstract][Full Text] [Related]
10. [Use of captopril and other angiotensin-converting enzyme inhibitors in patients with myocardial infarction].
Preobrazhenskiĭ DV
Kardiologiia; 1993; 33(12):48-52. PubMed ID: 8196257
[No Abstract] [Full Text] [Related]
11. Effect of angiotensin converting enzyme inhibitor (captopril) on gastric ulcer production in pylorus ligated rats.
Rao SP; Sathiamoorthy A; Sathiamoorthy SS
Indian J Physiol Pharmacol; 1995 Jul; 39(3):296-8. PubMed ID: 8550131
[TBL] [Abstract][Full Text] [Related]
12. [The effect of a combination ACE inhibitor and beta-blockers in acute myocardial infarct].
Di Pasquale P; Paterna S
G Ital Cardiol; 1999 Aug; 29(8):938-42. PubMed ID: 10488458
[No Abstract] [Full Text] [Related]
13. The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Hamon M; Filippi-Codaccioni E;
Lancet; 2002 Dec; 360(9348):1886-7. PubMed ID: 12480397
[No Abstract] [Full Text] [Related]
14. The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Chowdhary S; Townend JN;
Lancet; 2002 Dec; 360(9348):1886. PubMed ID: 12480396
[No Abstract] [Full Text] [Related]
15. The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Martínez-Sellés M;
Lancet; 2002 Dec; 360(9348):1885; author reply 1885. PubMed ID: 12480394
[No Abstract] [Full Text] [Related]
16. The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
Fournier A; Andrejak M; Slama M; Godefroy O; Achard JM;
Lancet; 2002 Dec; 360(9348):1885-6. PubMed ID: 12480393
[No Abstract] [Full Text] [Related]
17. Beneficial effects of captopril in coxsackievirus myocarditis.
Matsumori A; Suzuki H; Kawai C
Circulation; 1990 Nov; 82(5):1882-3. PubMed ID: 2171809
[No Abstract] [Full Text] [Related]
18. [Comparative assessment of antihypertensive effects of angiotensin-converting enzyme inhibitors ramipril and captopril in patients with hypertension in ambulatory settings].
Lebedev AV; Kukushkin SK; Manoshkina EM; Shamarin VM; Deev AD
Kardiologiia; 2003; 43(3):71-2. PubMed ID: 12913982
[No Abstract] [Full Text] [Related]
19. [Treatment of hypertension using converting enzyme inhibitors].
Kolber-Postepska B
Wiad Lek; 1987 Aug; 40(16):1104-10. PubMed ID: 3326286
[No Abstract] [Full Text] [Related]
20. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
Hradec J
Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
